LAUREN SMITH: Open Payments
NPI 1053174821 · WEATHERFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,570 in 72 payments from 34 companies in 2025. Trend: 2023 $0 · 2024 $2,459 · 2025 $2,570
Food & beverage: $1,472Long term medical supply or device loan: $1,098
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $1,193 |
| Janssen Biotech, Inc. | 6 | $228 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $121 |
| Merck Sharp & Dohme LLC | 4 | $98 |
| ABBVIE INC. | 3 | $82 |
| Gilead Sciences, Inc. | 3 | $56 |
| BeOne Medicines USA, Inc. | 3 | $51 |
| SOBI, INC | 2 | $49 |
| Lilly USA, LLC | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $43 |
Products named: KISQALI, NERLYNX, RYBREVANT, Trodelvy, EPKINLY, KEYTRUDA, Doptelet, CARVYKTI.
Industry payments across TX — which companies pay providers there.
